Drug Database
L01CE02 irinotecan
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM CAMPTO 20 mg/ml, concentrate for solution for infusion (100mg & 300mg presentation)
- POM Campto 20mg/ml concentrate for solution for infusion (40mg presentation)
- POM Irinotecan 1.5 mg/ml solution for infusion
- POM Irinotecan hydrochloride 20 mg/ml concentrate for solution for infusion
- POM Irinotecan Hydrochloride 20 mg/ml Concentrate for Solution for Infusion
- POM Irinotecan Hydrochloride Accord 20 mg/ml Concentrate for Solution for Infusion
- POM Irinotecan Hydrochloride medac 20 mg/ml, concentrate for solution for infusion
- POM ONIVYDE pegylated liposomal 4.3 mg/ml concentrate for dispersion for infusion
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).